Bangor University and Verily: Revolutionising Wastewater Monitoring
Since its inception in 2020, in response to the COVID-19 pandemic, Bangor University’s award winning wastewater lab has become a leader in environmental bio-surveillance in the UK. In September 2024, Bangor announced a partnership with Verily , a precision health technology company, to expand its wastewater monitoring program. Currently, Verily and Bangor University are working to onboard customers, including governments and life science companies, for both wastewater testing and generating unique insights from wastewater data. 1
State-of-the-Art Laboratory at Bangor University
The Bangor University lab, led by Davey Jones, PhD, a noted Professor of Environmental Science & Public Health and Associate Pro-Vice-Chancellor at Bangor University, is adopting Verily’s advanced wastewater testing technology to deliver high-quality public health data, crucial for tracking virus transmission and bolstering research and development efforts across both the public and private sectors. With this collaboration, the lab is extending its testing service capabilities to a wide range of human pathogens, including Norovirus, influenza viruses, MPXV, SARS-CoV-2, antimicrobial resistant bacteria, and fungi. The lab will also accelerate new capability development, including environmental testing. Professor Jones and his team will continue to lead operations in the Bangor University laboratory, in partnership with Verily. 2
Services: Advanced Pathogen Detection and Public Health Insights
We work with government agencies, academic institutions, and commercial R&D organisations to establish and manage wastewater monitoring programs from site identification through returning results.
Our facilities can provide all the logistics support to efficiently onboard sites and manage sample collection, offers quantitative analysis to measure pathogen concentrations, genomic sequencing, and data delivery under ISO 17025.
Respiratory:
- SARS-CoV-2 (quantitative and sequencing)
- RSV
- Influenza A (IAV)
- H1, H5 IAV subtypes
- Influenza B (IBV)
- Measles
Gastroenteric:
- Norovirus GI, GII
- Sapovirus
- Adenovirus
- Enterovirus
- Poliovirus (sequencing only)
- Enterovirus-D68
- Hepatitis A virus
- Hepatitis E virus
- Rotavirus
Other:
- Mpox virus - clade 1, clade 1b, clade 2
- Scabies
- Faecal indicator crAssphage
- Faecal indicator pepper mild mottle virus
- Sample collection from WWTPs, facilities near-source (e.g. hospital, prison), or from the environment
- Sample processing of liquid influent, treated effluent, settled solids from a primary clarifier, or surface water/sediment/shellfish samples.
- Samples collection by the client or sampling regime can be organised and conducted by Bangor.
- Quantitative analysis conducted using quantitative PCR technology
- Analyses of the physico-chemical properties (pH, electric conductivity, turbidity, suspended solids, ammonium, orthophosphate) within the samples can be added.
- Results turnaround approximately within 24 hours of receipt at the Bangor lab.
- UKAS accredited to ISO 17025.
- Quantitative data provided in genome copies per litre or normalised by population.
Why Choose Bangor University and Verily?
Further information
We appreciate you wanting to learn more about Bangor University's and Verily's Wastewater-based epidemiology program. For more information, and pricing, connect with us.
Wastewater Research Brambell Building University, Deiniol Rd, Bangor LL57 2UR